Has Sharon Yee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,949 in general payments to Sharon Yee, MD across 1,042 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sharon Yee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sharon Yee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sharon Yee, MD

Hospice and Palliative Medicine · Arcadia, CANPI 1215027560

Payments from drug & device makers

$43,949in general payments, 2019–2025

Across 1,042 payments — averaging $42.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$6K
Gilead$6K
Seagen Inc.$6K
Incyte Corporation$6K
AstraZeneca$3K
Geron Corporation$3K
plus $15K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	147	$5,833
Gilead(2 entities)	59	$5,770
Seagen Inc.	8	$5,566
Incyte Corporation	119	$5,538
AstraZeneca(2 entities)	67	$3,025
Geron Corporation	6	$2,875
CTI Biopharma Corp.	1	$1,725
Exelixis Inc.	68	$1,511
Novartis	88	$1,393
Pfizer	57	$1,039
Astellas Pharma US Inc	40	$1,038
Genentech USA, Inc.	47	$907
Bristol Myers Squibb	33	$738
Takeda Pharmaceuticals U.S.A., Inc.	18	$681
Karyopharm Therapeutics Inc.	28	$553
GSK	20	$545
Puma Biotechnology, Inc.	18	$487
Bayer	19	$423
Merck	17	$385
AbbVie	14	$377
Amgen	16	$361
Pharmacyclics LLC, An Abbvie Company	11	$283
Boehringer Ingelheim	13	$254
Beone Medicines USA, Inc.	6	$232
Sobi, Inc	7	$208
Myovant Sciences Inc.	18	$159
E.r. Squibb & Sons, L.L.C.	9	$159
Organon	9	$158
Agios Pharmaceuticals, Inc.	7	$156
Eisai Inc.	7	$144
Sumitomo Pharma America, Inc.	8	$144
Pharmaessentia USA Corporation	5	$120
EMD Serono, Inc.	4	$117
Progenics Pharmaceuticals, Inc.	5	$104
Lilly USA, LLC	4	$94
Dendreon Pharmaceuticals LLC	4	$90
Beigene USA, Inc.	4	$86
Regeneron Healthcare Solutions, Inc.	4	$83
Sanofi	3	$77
Tesaro, Inc.	3	$71
Global Blood Therapeutics, Inc.	2	$49
Syndax Pharmaceuticals, Inc.	2	$44
Mirati Therapeutics, Inc.	2	$44
Tolmar Pharmaceuticals, Inc.	2	$43
Jazz Pharmaceuticals Inc.	2	$41
Lexicon Pharmaceuticals, Inc.	1	$24
Tersera Therapeutics LLC	1	$23
Deciphera Pharmaceuticals Inc.	1	$23
Morphosys, US Inc.	1	$23
Immunomedics, Inc.	1	$22
Caris MPI, Inc.	1	$21
Alnylam Pharmaceuticals Inc.	1	$18
Teva Pharmaceuticals USA, Inc.	1	$17
Verastem, Inc.	1	$16
Tolmar, Inc.	1	$14
Cumberland Pharmaceuticals, Inc.	1	$14

How this compares

$43,949 in reported general payments places this provider in the 95th percentile of 195 hospice and palliative medicine providers in California.

See all hospice and palliative medicine providers in California →

Medicare billing

Part B allowed, 2024

$149,469

Medicare patients

193

Services billed

5,880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospice and palliative medicine in Arcadia

John HausdorffMonterey$68K
Neil SoniFountain Valley$28K
Marietta Abalos-GalitoSan Jose$22K
Humayon KhanSanta Ana$7K
Sorin BugaDuarte$5K
Glenn CarrFresno$5K
Steven HarrisFoster City$5K
Christopher PhillipsMurrieta$4K
William DaleDuarte$3K
Nehal PatelLaguna Hills$3K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →